n(1)-methylnicotinamide has been researched along with Idiopathic Parkinson Disease in 3 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukushima, T | 3 |
Tawara, T | 1 |
Isobe, A | 1 |
Hojo, N | 1 |
Shiwaku, K | 1 |
Yamane, Y | 1 |
Kaetsu, A | 1 |
Lim, H | 1 |
Moriyama, M | 1 |
1 review available for n(1)-methylnicotinamide and Idiopathic Parkinson Disease
Article | Year |
---|---|
[Elucidation of paraquat poisoning mechanism and development of the neuronal death model].
Topics: Animals; Chaperonin 60; Disease Models, Animal; Electron Transport Complex I; Herbicides; Humans; Li | 2002 |
2 other studies available for n(1)-methylnicotinamide and Idiopathic Parkinson Disease
Article | Year |
---|---|
Radical formation site of cerebral complex I and Parkinson's disease.
Topics: Animals; Brain; Cattle; Electrophoresis, Polyacrylamide Gel; Hydrogen-Ion Concentration; Hydroxyl Ra | 1995 |
Possible role of 1-methylnicotinamide in the pathogenesis of Parkinson's disease.
Topics: Animals; Brain; Cell Fractionation; Cytosol; Dopamine; Dose-Response Relationship, Drug; Gas Chromat | 2002 |